REFERENCE
1. de Souza A W, de Carvalho J F. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun . 2014;48-49(79-83).
2. Grayson P C, Cuthbertson D, Carette S, et al. New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol . 2013;40(11):1905-1912.
3. Tombetti E, Di Chio M C, Sartorelli S, et al. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther . 2014;16(6):479.
4. Dogan S, Piskin O, Solmaz D, et al. Markers of endothelial damage and repair in Takayasu arteritis: are they associated with disease activity?Rheumatol Int . 2014;34(8):1129-1138.
5. Sjoberg A P, Trouw L A, Blom A M. Complement activation and inhibition: a delicate balance. Trends Immunol . 2009;30(2):83-90.
6. Castellano G, Woltman A M, Nauta A J, et al. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood . 2004;103(10):3813-3820.
7. Tan Y, Song D, Wu L H, et al. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. BMC Nephrol . 2013;14(63.
8. Wu F Q, Zhao Q, Cui X D, et al. C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int . 2011;31(4):501-505.
9. Gilliam B E, Reed M R, Chauhan A K, et al. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation. Clin Exp Rheumatol . 2011;29(6):1049-1056.
10. Li L, Chen J, Chen S, et al. Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.Ann Clin Lab Sci . 2019;49(2):237-241.
11. Arend W P, Michel B A, Bloch D A, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.Arthritis Rheum . 1990;33(8):1129-1134.
12. Kerr G S, Hallahan C W, Giordano J, et al. Takayasu arteritis. Ann Intern Med . 1994;120(11):919-929.
13. Ueno A, Awane Y, Wakabayashi A, et al. Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J . 1967;8(5):538-544.
14. Lupi E, Sanchez G, Horwitz S, et al. Pulmonary artery involvement in Takayasu’s arteritis. Chest . 1975;67(1):69-74.
15. Vaideeswar P, Deshpande J R. Pathology of Takayasu arteritis: A brief review. Ann Pediatr Cardiol . 2013;6(1):52-58.
16. Chimenti M S, Ballanti E, Triggianese P, et al. Vasculitides and the Complement System: a Comprehensive Review. Clin Rev Allergy Immunol . 2015;49(3):333-346.
17. Gyotoku Y, Kakiuchi T, Nonaka Y, et al. Immune complexes in Takayasu’s arteritis. Clin Exp Immunol . 1981;45(2):246-252.
18. Ohyama K, Baba M, Tamai M, et al. Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases. Clin Biochem . 2015;48(3):181-185.
19. Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res . 2015;63(1-3):101-106.
TABLE 1 Demographic, clinical characteristics and laboratory findings between TA patients and healthy controls